In Vivo Imaging of Mineral Deposition in Carotid Plaque Using 18F-sodium Fluoride PET/CT: Correlation with Atherogenic Risk Factors
Overview
Authors
Affiliations
Unlabelled: The purpose of this study was to correlate (18)F-sodium fluoride accumulation in the common carotid arteries of neurologically asymptomatic patients with cardiovascular risk factors and carotid calcified plaque burden.
Methods: Two hundred sixty-nine oncologic patients were examined by (18)F-sodium fluoride PET/CT. Tracer accumulation in the common carotid arteries was analyzed both qualitatively and semiquantitatively by measuring the blood-pool-corrected standardized uptake value (target-to-background ratio) and comparing it with cardiovascular risk factors and calcified plaque burden.
Results: (18)F-sodium fluoride uptake was observed at 141 sites in 94 (34.9%) patients. Radiotracer accumulation was colocalized with calcification in all atherosclerotic lesions. (18)F-sodium fluoride uptake was significantly associated with age (P < 0.0001), male sex (P < 0.0001), hypertension (P < 0.002), and hypercholesterolemia (P < 0.05). The presence of calcified plaque correlated significantly with these risk factors but also with diabetes (P < 0.0001), history of smoking (P = 0.03), and prior cardiovascular events (P < 0.01). There was a highly significant correlation between the presence of (18)F-sodium fluoride uptake and number of present cardiovascular risk factors (r = 0.30, P < 0.0001).
Conclusion: Carotid (18)F-sodium fluoride uptake is a surrogate measure of calcifying carotid plaque, correlates with cardiovascular risk factors, and is more frequent in patients with a high-risk profile for atherothrombotic events but demonstrates a weaker correlation with risk factors than does calcified plaque burden. This study provides a rationale to conduct further prospective studies to determine whether (18)F-sodium fluoride uptake can predict vascular events, or if it may be used to monitor pharmacologic therapy.
Patil S, Kata R, Teichner E, Subtirelu R, Ghonim M, Ghonim M Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39939531 DOI: 10.1007/s00259-025-07127-z.
Rubinstein G, Ilhan H, Bartenstein P, Lehner S, Hacker M, Todica A Diagnostics (Basel). 2024; 14(22).
PMID: 39594152 PMC: 11593158. DOI: 10.3390/diagnostics14222486.
Bhakta S, Tarkin J, Chowdhury M, Rudd J, Warburton E, Evans N Int J Stroke. 2024; 19(10):1155-1161.
PMID: 38888039 PMC: 11590389. DOI: 10.1177/17474930241264734.
Ueda C, Flausino Dias L, de Godoi Carneiro C, Sapienza M, Buchpiguel C, Duarte P Arch Endocrinol Metab. 2024; 68:e230152.
PMID: 38602746 PMC: 11081049. DOI: 10.20945/2359-4292-2023-0152.
Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights.
Zaslow S, Oliveira-Paula G, Chen W Int J Mol Sci. 2024; 25(2).
PMID: 38256228 PMC: 10816532. DOI: 10.3390/ijms25021155.